Ketorolac Tromethamine Injection, USP (2015-06-30)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
| Lot or serial number | Companies | Brand name | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| 41526DK | - Recalling Firm
- Hospira Healthcare Corporation
- 2600 Boul. Alfred-Nobel, Suite 100
- St Laurent
- H4S 0A9
- Quebec
- CANADA
- Marketing Authorization Holder
- Hospira Healthcare Corporation
- 2600 Boul. Alfred-Nobel, Suite 100
- St Laurent
- H4S 0A9
- Quebec
- CANADA
| Ketorolac Tromethamine Injection, USP | Solution | DIN 02390582 | Ketorolac Tromethamine 30 mg / mL |
Recalled Products
Ketorolac Tromethamine Injection, USP
Potential for presence of particulate matter in the glass vials containing Ketorolac.
Wholesalers and Hospitals